Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-075194

Chief Financial Officer acquired 7,478 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Ruffo Frank · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2015-10-13 Conversion : show line 1 in the form +7,478 137,912 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2015-10-13 Conversion : show line 2 in the form Series A Preferred Stock −20,000 0 D
2015-10-13 Conversion : show line 3 in the form Series B Preferred Stock −5,802 0 D
Loading xslF345X03/doc4.xml…